Fibrinolytic or not : case series of stemi and deadly hemorrhagic stroke
Cardiovascular diseases (CVD) like myocardial infraction (MI) is still becoming the leading cause of morbidity and mortality and major problem in our healthcare system. Nowadays, revolution in high-tech medical treatment alongside with well-trained staff could decrease adverse event in ST elevation...
Main Authors: | Sidhi Laksono Purwowiyoto, Steven Phillip |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Universitas Pembangunan Nasional Veteran Jakarta
2020-05-01
|
Series: | Jurnal Profesi Medika |
Subjects: | |
Online Access: | https://ejournal.upnvj.ac.id/index.php/JPM/article/view/1055 |
Similar Items
-
Efficacy and safety of local fibrinolytic therapy in intracranial hemorrhages: A systematic review and meta-analysis of randomised controlled trials
by: Arun Babu Rajeswaran, et al.
Published: (2024-04-01) -
Abstract 1122‐000171: Unusual Multicompartmental Intracranial Hemorrhage After Tenecteplase Administration
by: Abdallah Amireh, et al.
Published: (2021-11-01) -
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
by: Hidesaku Asakura, et al.
Published: (2020-09-01) -
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
by: Rajni Singh, et al.
Published: (2023-11-01) -
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
by: Annie Zhu, et al.
Published: (2022-08-01)